ℹ️ Compiled from public regulatory records · Last regulator revision: August 18, 2023🚩 Report this page
Lithium
Lithium
US FDA
- Drug class
- Lithium
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
Overview
Lithium is an active pharmaceutical ingredient in the Lithium group (N05AN). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | August 18, 2023 |
USUnited States· FDA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Sources & citations
- [1]FDA DailyMed · 03389426-36da-99… · revised August 18, 2023 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.